The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A pan-tumor prospective translational, Irish study, investigating the association of gut microbiome (GM) diversity with pathological complete response (pCR) after neoadjuvant treatment in early stage breast, rectal, and esophageal cancers.
 
Christopher Cronin
No Relationships to Disclose
 
Ronan Andrew Mc Laughlin
Honoraria - Merck
Travel, Accommodations, Expenses - MSD; Pfizer; Takeda
 
Ciaran Devoy
No Relationships to Disclose
 
Carolyn Moloney
No Relationships to Disclose
 
Orla Fitzpatrick
No Relationships to Disclose
 
David Mcmahon
Consulting or Advisory Role - Pfizer
Travel, Accommodations, Expenses - Pfizer; Takeda
 
Michael R Conroy
Travel, Accommodations, Expenses - MJH Life Sciences
 
David O'Reilly
No Relationships to Disclose
 
Maciej Milewski
No Relationships to Disclose
 
Keith Egan
No Relationships to Disclose
 
Kathleen Bennett
No Relationships to Disclose
 
Megan Greally
No Relationships to Disclose
 
Adrian Gerard Murphy
Consulting or Advisory Role - Abbvie
Speakers' Bureau - Bayer Schering Pharma
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bayer Schering Pharma; Nordic Drugs
 
Jarushka Naidoo
Honoraria - Abbvie/Genentech; Amgen; Arcus Biosciences; AstraZeneca/MedImmune; Bristol-Myers Squibb; Daiichi Sankyo/Lilly; Daiichi Sankyo/Lilly; Elevation Oncology; Kaleido Biosciences; Merck; Mirati Therapeutics; NGM Biopharmaceuticals; Pfizer; Regeneron; Roche/Genentech; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Arcus Biosciences; AstraZeneca/MedImmune; Bristol-Myers Squibb; Daiichi Sankyo/Lilly; Elevation Oncology; Kaleido Biosciences; Merck; Merck KGaA; Mirati Therapeutics; NGM Biopharmaceuticals; Pfizer; Regeneron; Roche/Genentech; Takeda
Research Funding - Amgen (Inst); AstraZeneca (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Takeda
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bristol-Myers Squibb; Pfizer
 
Patrick G. Morris
Honoraria - AstraZeneca; Genomic Health; Gilead Sciences; Novartis; Novartis; Pfizer; Roche; Seagen
Consulting or Advisory Role - Novartis
Research Funding - Genomic Health (Inst); Teva
Travel, Accommodations, Expenses - Roche/Genentech
 
Oscar S. Breathnach
No Relationships to Disclose
 
William Grogan
No Relationships to Disclose
 
Sinead Toomey
No Relationships to Disclose
 
Mark Tangney
No Relationships to Disclose
 
Bryan T. Hennessy
No Relationships to Disclose